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Abstract 
Depression and hopelessness predict myocardial infarction (MI), but it is unclear whether 
depression and hopelessness are independent predictors of MI incidents.  Hopelessness, 
depression, and MI incidence rate 18 years later were measured in 2005 men.  Cox regressions 
were conducted with hopelessness and depression serving as individual predictors of MI.  
Another Cox model examined whether the two predictors predict MI when adjusting for each 
other.  Depression and hopelessness predicted MI in independent regressions but when adjusting 
for each other, hopelessness, but not depression, predicted MI incidents.  Thus, these results 
suggest that depression and hopelessness are not independent predictors of MI. 
 
Keywords: population-based; longitudinal follow-up study; hopelessness; depressive symptoms; 
myocardial infarction 
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The Global Burden of Disease study launched by the World Health Organization predicts 
coronary heart disease (CHD) (incl. myocardial infarction; MI) and depression will be two of the 
three most disabling disorders worldwide by 2030, only surpassed by HIV/AIDS (Mathers and 
Loncar, 2006).  In high-income countries, including the USA, depression and CHD will be the 
two most disabling disorders with 15.7% of total disability-adjusted life years (DALYS).  
Beyond this, CHD is the number one cause of death globally and in high-income countries and is 
projected to remain the leading cause of death with 13.4% and 15.8% of total deaths, 
respectively (Mathers and Loncar, 2006).  Currently, an estimated 83.6 million or 1/3 of all 
American adults have one or more types of CHD and this number is projected to increase to 
40.8% by the year 2030 (American Heart Association, 2013).  Additionally, CHD was the 
underlying cause of death in 32.3% of all deaths in 2009; it is the leading cause of death for both 
males and females (American Heart Association, 2013).  
Several empirical studies have demonstrated that depressive symptoms are prospectively 
associated with incidence of CHD (Leung et al., 2012; Nicholson et al., 2006; Van der Kooy et 
al., 2007), even after adjusting for other risk factors.  For example, the Canadian National 
Population Health Survey revealed that after adjusting for gender and age, depressive symptoms 
increase the risk for hypertension and heart disease two years later (Patten et al., 2008).  Further 
recent research indicates that the association between depressive symptoms and future CHD 
incidents is particularly strong in men (Fiedorowicz et al., 2011).  Finally, a systematic review 
identified 22 longitudinal studies researching depressive symptoms as a risk factor for the 
development of CHD (Kuper et al., 2002).  In this review, 15 of the identified studies supported 
a link between depressive symptoms and CHD, while only 7 could not provide a clear link. 
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Increased knowledge about the relationship between depressive symptoms and CHD 
opens possibilities for new ways of attenuating the influence of depressive symptoms on CHD 
(Grippo and Johnson, 2002).  Consistent with this consideration, recent literature reflects an 
interest in identifying which specific aspects of depression are strong predictors of CHD.  For 
example, particular cognitive aspects of depressive symptoms (incl. pessimism, past failure, self-
criticalness, worthlessness) were associated with cardiac morbidity and mortality in a study with 
coronary artery bypass graft patients (Tully et al., 2011).  Another cognitive aspect of depression 
is hopelessness- the negative view of the future.  Hopelessness is characterized as a “toxic” 
symptom of depression and it often occurs with severe episodes of depression (Brown and 
Harris, 1978).  Nevertheless, hopelessness is not recognized as a symptom of depression in the 
DSM-IV-TR (American Psychiatric Association, 2000) and two prominent models explaining 
the development and maintenance of depression identify hopelessness as a risk factor and not as 
a symptom of depression (Abramson et al., 1989; Beck, 1976).  Thus, hopelessness may be 
distinct from depression in its associations with CHD.   
This hypothesis is supported by multiple studies.  For example, a 12-year longitudinal 
study with 45 to 77 year-old adults without a history of CHD or other serious illness at baseline 
revealed that the relative risk of fatal and nonfatal CHD increased by 50% and 40%, 
respectively, for each increase in level of hopelessness after adjusting for age, gender, ethnicity, 
marital status, smoking, total cholesterol, systolic blood pressure, body mass index, alcohol use, 
and physical activity (Anda et al., 1993).  Furthermore, moderate levels of hopelessness 
increased the relative risk of fatal and nonfatal CHD by approximately 50% more than 
depressive symptoms.  Everson et al. (1996) revealed in their population-based longitudinal 
study that for men with no known history of angina pectoris or MI, those reporting high levels of 
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hopelessness were at a significantly increased risk for a first MI, relative to men scoring low on 
the measure for hopelessness.  Men with moderate levels of hopelessness showed a 20% to 30% 
increased risk of MI, relative to men with low hopelessness scores, but these elevations were not 
significant.  While Everson et al. (1996) tested the association between hopelessness and CHD 
incidents, after adjusting for depressive symptoms, the relationship between depressive 
symptoms and CHD has not been studied while adjusting for hopelessness.   
The cross-sectional Study of Women’s Health Across the Nation Heart Study (SWAN; 
Whipple et al., 2009) with healthy women found that hopelessness significantly predicted mean 
and maximum carotid artery intima-media thickening (IMT) while depressive symptoms 
predicted IMT only marginally, both while adjusting for age, race/ethnicity (i.e., European 
American and African-American), income, BMI, SBP, and smoking.  Moreover, after entering 
both hopelessness and depressive symptoms in the same model and continuing to adjust for all 
other variables, hopelessness but not depressive symptoms remained a significant predictor of 
IMT.  Other publications have found that hopelessness predicts hypertension (Everson et al., 
2000) and carotid atherosclerosis (Pollitt et al., 2005), both biological risk factors of CHD, even 
after adjusting for depressive symptoms.  Given these findings, the question of whether 
hopelessness and depressive symptoms are longitudinally and independently associated with 
CHD becomes important to address. 
Based on the above theoretical considerations (Abramson et al., 1989; Beck, 1976) and 
empirical findings (Anda et al., 1993; Everson et al., 1996; 2000; Pollitt et al., 2005; Whipple et 
al., 2009), in this study we predicted that hopelessness would be associated with depressive 
symptoms and MI incidents up to 18 years later.  Further, we expected that the association 
between depressive symptoms and MI incidents would no longer be significant when adjusting 
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for hopelessness, whereas the association between hopelessness and MI incidents were predicted 
not to be influenced by depressive symptoms. 
Methods 
Participants 
This study utilized data collected as part of the Kuopio Ischemic Heart Disease (KIHD) 
study, a longitudinal population-based study examining risk factors of several serious health 
conditions (e.g., MI).  Participants were enrolled in the study between March 1984 and 
December 1989, and the population consisted of 2682 men.  Further details to recruitment and 
population are described in previous publications (Salonen, 1988).  In the current analysis, 
participants were excluded from further analyses if they had experienced a CHD prior to baseline 
to remove the effectof CHD on depressive symptoms.  Thus, 2005 men remained for 
examination, with an age range extending from 42 to 61 and a mean (SD) of 52.45 (5.32).  All 
participating men gave their informed consent prior to their inclusion in the study, and the study 
followed the ethical standards of the Helsinki Declaration. 
Measures 
Hopelessness Scale (Everson et al., 1996).  The hopelessness scale is comprised of two 
items assessing the degree to which an individual experiences feelings of hopelessness.  The 
items were “I feel that it is impossible to reach the goals I would like to strive for” and “The 
future seems to me to be hopeless, and I can't believe that things are changing for the better.”  
Participants responded to the items based on a 5-point Likert scale, ranging from 0 (absolutely 
agree) to 5 (absolutely disagree).  To obtain a score on the hopelessness scale, the two items 
were reverse-coded and then summed.  Hopelessness scores ranged from 0 to 8 with a mean 
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(SD) of 2.51 (1.95).  Internal consistency for the items with this particular population was α = 
.70. 
The Human Population Laboratory Depression Scale (HPLDS; Roberts and 
O’Keefe, 1981).  The HPLDS is comprised of 18 items and assesses the degree to which an 
individual experiences depressive symptomatology.  No items assessing hopelessness are 
included in the HPL.  Participants responded to each item utilizing a true-false format, and 
depression scores were calculated by assigning a one-point value to each item that endorsed a 
depressive symptom and summing all of the items.  Internal consistency for the items with this 
population was α = .71.  The HPLDS was developed to assess depressive symptoms in 
population-based samples and prior studies have utilized it to do such (Everson et al., 1998; 
Kaplan et al., 1987; Roberts et al., 1981; Tolmunen et al., 2004).   
Myocardial Infarctions.  Data on MI were obtained from the National Hospital 
Discharge Data Register by record linkage.  The diagnostic classification of coronary events was 
based on symptoms, electrocardiographic findings, and cardiac enzyme elevations.  Each 
suspected coronary event was coded according to the Ninth (code numbers 410–414; Centers for 
Disease Control and Prevention, 1998) or Tenth (code numbers I20–I25; World Health 
Organization, 2007) revision of the International Classification of Diseases (ICD) and was 
classified into (1) a definite MI, (2) a probable MI, (3) a typical acute chest pain episode of more 
than 20 min, indicating CHD, (4) an ischaemic cardiac arrest with successful resuscitation, or (5) 
no acute coronary event.  The diagnosis was made by a physician using original patient records.  
All MI cases that occurred from the study entry until 31st December 2005 were included.  Thus, 
average follow-up time was 15.2 years (range 12.3 to 18.0 years).  In the present sample, 384 
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men (19.2%) experienced a MI between baseline and follow-up.  If a participant had multiple 
events, the first event was considered as the end point. 
Data Analysis 
To test the hypotheses that hopelessness predicts both depressive symptoms and MI 
incidents and depressive symptoms is not an independent predictor of MI, one partial correlation 
and three different Cox proportional hazards regression models with MI as the dependent 
variable were calculated.  First, a partial correlation between hopelessness and depressive 
symptoms was calculated.  Second, two separate Cox models with hopelessness or depressive 
symptoms as predictors of MI incidents were calculated.  Third, one Cox model with 
hopelessness and depressive symptoms as predictors of MI incidents was calculated.  Finally, 
two paired t-tests were used to compare the regression weights in the Cox models with only one 
predictor (hopelessness or depressive symptoms) to the regression weights in the Cox models 
with both predictors (hopelessness and depressive symptoms).  A significant t-test reveals that 
the regression between a predictor (e.g., depressive symptoms) and MI is substantially reduced 
by the introduction of the other predictor (e.g., hopelessness).  In other words, the association 
between the first predictor (e.g., depressive symptoms) and MI is not independent from the 
second predictor (e.g., hopelessness; Haibe-Kains et al., 2008; Student, 1908). 
The hypotheses would be correct when (a) hopelessness and depressive symptoms 
significantly correlate with each other; (b) both variables predict MI incidents when not adjusted 
for each other; (c) the regression weight of depressive symptoms, but not of hopelessness, is 
susbtantially reduced when comparing the regression weights in the Cox models with only one 
predictor (hopelessness or depressive symptoms) to the regression weights in the Cox models 
with both predictors (hopelessness and depressive symptoms; Haibe-Kains et al., 2008; Student, 
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1908).  All analyses (partial correlation and three Cox models) were adjusted for age, waist to 
hip ratio, low-density lipoprotein and high-density lipoprotein cholesterol levels, and resting 
systolic blood pressure.   
Results 
Depressive symptoms and hopelessness correlated with r = .33 (p < .001) independent of 
adjustment for the influence of the control variables mentioned above.  The adjusted Cox 
proportional hazards regression model with depressive symptoms as predictor of MI incidence 
revealed that higher depression scores were significantly associated with an increased risk for an 
MI (p = .047; Table 1).  Moreover, the adjusted Cox model with hopelessness as predictor of MI 
incidence revealed that higher hopelessness scores were significantly associated with an 
increased risk for an MI (p = .011; Table 1).  The adjusted Cox model that included both 
depressive symptoms and hopelessness as predictors of MI revealed that higher hopelessness 
scores (p = .047), but not depression scores (p = .212), remained significantly associated with an 
increased risk of an MI (Table 1).  
Finally, paired t-tests comparing the regression weights in the Cox models with only one 
predictor (depressive symptoms or hopelessness) with the regression weights in the Cox models 
with both predictors (depressive symptoms and hopelessness) were calculated.  These tests 
revealed that the regression weight of depression scores was significantly reduced when 
adjusting for hopelessness (t(2004) = 2.18; p = .029), while the regression weight of 
hopelessness did not change significantly when adjusting for depressive symptoms (t(2004) = 
1.608; p = .108). 
Discussion 
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The aim of this study was to test whether depressive symptoms and hopelessness are 
independent predictors of MI incidents (as one type of CHD).  Consistent with the predictions, 
depressive symptoms and hopelessness correlated significantly with each other.  Moreover, 
consistent with the hypothesis and previous empirical findings, depressive symptoms 
(Fiedorowicz et al., 2011; Nicholson et al., 2006; Patten et al., 2008; Van der Kooy et al., 2007) 
and hopelessness (Anda et al., 1993; Everson et al., 1996, 2000; Whipple et al., 2009) predicted 
MI incidents up to 18 years later when not adjusting for each other.  Additionally, hopelessness 
remained a preditor of MI incidents, even after adjusting for depressive symptoms.  Finally, the 
association between depressive symptoms at baseline and MI incidents was significantly reduced 
when adjusting for hopelessness, while the asssociation between baseline hopelessness and MI 
incidents did not change when adjusting for depressive symptoms.  Summarized, the results are 
consistent with the hypothesis that hopelessness but not depressive symptoms is an independent 
predictor of MI.   
Based on previous studies establishing depressive symptoms as risk factor for MI 
incidents (Fiedorowicz et al., 2011; Nicholson et al., 2006; Patten et al., 2008; Van der Kooy et 
al., 2007), multiple studies have attempted to reduce biological risk factors of MI incidents (e.g., 
Bot et al., 2011) or MI reoccurence itself (e.g., Glassman et al., 2009) by reducing depressive 
symptoms in patients with CHD.  However, a recent meta-analysis of studies researching the 
effects of pharmacotherapeutic interventions to reduce depressive symptoms in patients with 
CHD did not improve the readmission and the mortality rate (Pizzi et al., 2011).  Not all 
pharmaco- and psychotherapeutic interventions effective in treating depressive symptoms impact 
hopelessness equally well (see Pössel and Hautzinger, 2006 for a review).  The finding of this 
study may provide one explanation for this particular finding in the meta-analysis.  Thus, future 
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studies of therapeutic approaches attempting to reduce MI incidents should study if a reduction 
of hopelessness as compared to a reduction of depressive symptoms improves MI incident rates. 
Although theoretical considerations (Abramson et al., 1989; Beck, 1976) led to the 
conclusion that hopelessness is a risk factor of both depressive symptoms and MI causing the 
impression of an association between depressive symptoms and MI incidents, it was not possible 
to test this hypothesis because depressive symptoms and hopelessness were measured in this 
study at the same time point.  To be able to test the direction of the associations, a study with at 
least three waves of data collection and equal time lags between the waves is needed (Cole and 
Maxwell, 2003).  This seems especially important given that some researchers conceptualize 
hopelessness as symptom of depression rather than a risk factor of depression (e.g., Do et al., 
2010), despite that hopelessness is not listed as a symptom in the DSM-IV-TR (APA, 2000).  
Thus, an alternative interpretation of our findings might be that hopelessness is simply the 
“active factor” that connects depression to MI.  Further possible explanations for our finding 
include but are not limited to (a) hopelessness may mediate the effect of depression on MI 
incidents, (b) a covariate may control for more variability in one predictor than in the other and 
thereby allow one predictor (e.g., hopelessness) to achieve greater predictive power relative to 
the other predictor (e.g., depressive symptoms), or (c) an omitted covariate (e.g., SES) is 
undercontrolled with respect to one predictor (e.g., hopelessness) but not another (e.g., 
depressive symptoms).  Thus, the findings call not only for replication but also for additional 
explorations of the interplay of hopelessness, depressive symptoms, and other variables on 
hypertension, atherosclerosis, and heart rate variability as biological risk factors of MI incidents 
and other CHDs. 
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Beyond that, while previous research has already studied the impact of some risk factors 
of depressive symptoms such as childhood abuse (Fuller-Thomson et al., 2010), perceived stress 
and perceived control (Cohen et al., 1999; Rosenbaum et al., 2012), a negative attribution style 
(Sanjuan et al., 2012), and low self-esteem (Stamatakis et al., 2004), many other risk factors of 
depressive symptoms have not yet been examined.  Considering that both above mentioned 
psychological models of depression propose multiple cognitive risk factors of depression 
(Abramson et al., 1989; Beck, 1976) and that many of these risk factors of depression influence 
each other (e.g., Pössel, 2011; Pössel and Knopf, 2011), studies including multiple psychosocial 
factors seem especially fruitful.  Further, multiple coping mechanisms like religious coping (Ai 
et al., 2013) and social support (Schmidt et al., 2012) are studied with cardiac or other severly ill 
patients.  Thus, it would be important to explore the effects of these coping mechanisms on the 
relationship between depressive symptoms and CHD as well.  Such studies will contribute to a 
further integration of psychological and biological models into a bio-psycho-social model of 
heart health. 
Strengths of this study were that it included a large population-based design, an extended 
follow-up, and detailed assessments of different psychological factors and cardiovascular risk 
factors.  However, hopelessness and depressive symptoms were measured using self-report 
questionnaires instead of structured interviews.  In addition, the 2-item hopelessness scale that 
was used is fairly simple and has not been compared with other hopelessness scales.  
Nevertheless, it has been well-validated and in previous studies it has predicted various 
cardiovascular and metabolic outcomes (Do et al., 2010; Valtonen et al., 2008).  Further, the 
cohort of this study included only middle-aged white men and the findings cannot be generalized 
to women or other ethnic groups.  Given that men and women have been shown to report 
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different levels of particular depressive symptoms, such as fatigue, gender is an especially 
important variable to consider in the context of generalization (e.g., Grace et al., 2013).  
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Table 1 
Cox proportional hazards regression models predicting myocardial infarctions from scores on depression and hopelessness scales 
 Depressive symptoms – MI Hopelessness – MI Hopelessness & Depressive 
symptoms – MI  
 M SD B (SE) HR (95% CI) B (SE) HR (95% CI) B (SE) HR (95% CI) 
Depressive 
symptoms 
1.59 1.91 0.06 (0.03) 1.06 (1.00-1.13)* --- ----- 0.04(0.03) 1.04 (0.98-1.11) 
Hopelessness 2.45 1.93 --- ----- 0.08 (0.03) 1.08 (1.02-1.15)* 0.07(0.03) 1.07 (1.00-1.14)* 
Covariates         
   Age 51.92 5.80 0.05 (0.01) 1.05 (1.03-1.08)*** 0.04 (0.01) 1.04 (1.02-1.07)*** 0.04(0.01) 1.04 (1.02-1.07)*** 
   Resting SBP 133.30 16.35 0.01 (0.00) 1.01 (1.01-1.02)*** 0.01 (0.00) 1.01 (1.01-1.02)*** 0.01(0.00) 1.01 (1.01-1.02)*** 
   LDL 3.93 0.96 0.34 (0.06) 1.40 (1.24-1.57)*** 0.34 (0.06) 1.40 (1.24-1.58)*** 0.34(0.06) 1.40 (1.24-1.58)*** 
   HDL 1.30 0.29 0.54 (0.22) 0.58 (0.38-0.90)* -0.45 (0.23) 0.64 (0.41-9.90)* -0.46(0.23) 0.63 (0.41-0.98)* 
   Waist-hip ratio 0.94 0.06 2.22 (0.89) 9.21 (1.62-52.43)* 2.60 (0.98) 13.39 (1.98-90.58)** 2.54(0.98) 12.63 (1.86-85.77)** 
Note. SBP = systolic blood pressure; LDL = low-density lipoprotein; HDL = high-density lipoprotein; Org. = Organizational  
*p < .05; **p < .01; ***p < .001 
